Genomic epidemiology of erythromycin-resistant Bordetella pertussis in China
Open Access
- 1 January 2019
- journal article
- research article
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 8 (1) , 461-470
Abstract
Macrolides such as erythromycin are the empirical treatment of Bordetella pertussis infections. China has experienced an increase in erythromycin-resistant B. pertussis isolates since they were first reported in 2013. Here, we undertook a genomic study on Chinese B. pertussis isolates from 2012 to 2015 to elucidate the origins and phylogenetic relationships of erythromycin-resistant B. pertussis isolates in China. A total of 167 Chinese B. pertussis isolates were used for antibiotic sensitivity testing and multiple locus variable-number tandem repeat (VNTR) analysis (MLVA). All except four isolates were erythromycin-resistant and of the four erythromycin-sensitive isolates, three were non-ptxP1. MLVA types (MT), MT55, MT104 and MT195 were the predominant types. Fifty of those isolates were used for whole genome sequencing and phylogenetic analysis. Genome sequencing and phylogenetic analysis revealed three independent erythromycin-resistant lineages and all resistant isolates carried a mutation in the 23S rRNA gene. A novel fhaB3 allele was found uniquely in Chinese ptxP1 isolates and these Chinese ptxP1-ptxA1-fhaB3 had a 5-fold higher mutation rate than the global ptxP1-ptxA1 B. pertussis population. Our results suggest that the evolution of Chinese B. pertussis is likely to be driven by selection pressure from both vaccination and antibiotics. The emergence of the new non-vaccine fhaB3 allele in Chinese B. pertussis population may be a result of selection from vaccination, whereas the expansion of ptxP1-fhaB3 lineages was most likely to be the result of selection pressure from antibiotics. Further monitoring of B. pertussis in China is required to better understand the evolution of the pathogen.Keywords
This publication has 53 references indexed in Scilit:
- Appearance of Macrolide-Resistant Bordetella pertussis Strains in ChinaAntimicrobial Agents and Chemotherapy, 2013
- Appearance of Bordetella pertussis Strains Not Expressing the Vaccine Antigen Pertactin in FinlandClinical and Vaccine Immunology, 2012
- The seroepidemiology of Immunoglobulin G antibodies against pertussis toxin in China: a cross sectional studyBMC Infectious Diseases, 2012
- Prevalence and Genetic Characterization of Pertactin-Deficient Bordetella pertussis in JapanPLOS ONE, 2012
- Antibiotic Sensitivity of 40 Mycoplasma pneumoniae Isolates and Molecular Analysis of Macrolide-Resistant Isolates from Beijing, ChinaAntimicrobial Agents and Chemotherapy, 2012
- Effect of Vaccination onBordetella pertussisStrains, ChinaEmerging Infectious Diseases, 2010
- Bordetella pertussisStrains with Increased Toxin Production Associated with Pertussis ResurgenceEmerging Infectious Diseases, 2009
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- Fast and accurate short read alignment with Burrows–Wheeler transformBioinformatics, 2009
- Significant Gene Order and Expression Differences inBordetella pertussisDespite Limited Gene Content VariationJournal of Bacteriology, 2006